Home > Healthcare > Drug Device Combination > Drug Filled Devices > Antidiabetics Market

Antidiabetics Market Size

  • Report ID: GMI504
  • Published Date: Jun 2020
  • Report Format: PDF

Antidiabetics Market Size

Antidiabetics Market size was USD 65.5 billion in 2019 and will grow at a CAGR of 10.7% from 2020 to 2026.

 

Antidiabetics Market

To understand key trends  
Download Free Sample
 

Increasing prevalence of diabetes across the globe will stimulate the market potential for antidiabetics drugs during forecast period. Need for effective treatment with low side effects will result into increasing R&D spending by pharmaceutical firms for drug development. Thus, escalating demand and adoption of antidiabetic drugs in developing as well as developed nations will boost the market growth in the upcoming period.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of antidiabetics exceeded USD 65.5 million in 2019.

The industry share of antidiabetics is expected to witness growth at over 10.7% CAGR from 2020 to 2026.

U.S. market will grow at 10.3% CAGR through 2026, says this GMI report.

Insulin market constituted significant industry share in 2019 and is expected to proceed at 12.4% CAGR up to 2026.

Insulin pump segment is forecast to progress at over 11% CAGR during the forecast years.

Some of the prominent business players operating in the antidiabetics industry include AstraZeneca, Novartis AG, Johnson & Johnson, Merck & Co. Inc., Pfizer and Sanofi.

Antidiabetics Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2019
  • Companies covered: 14
  • Tables & Figures: 276
  • Countries covered: 15
  • Pages: 202
 Download Free Sample